Status:
COMPLETED
Orange Juice and Glycaemic Control in Type 2 Diabetes Mellitus
Lead Sponsor:
Hasselt University
Collaborating Sponsors:
Hochschule Geisenheim University
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
25-75 years
Phase:
NA
Brief Summary
The evidence on the consumption of 100% orange juice in people with type 2 diabetes is highly variable and largely out-of-date, with a few studies reporting acute negative glycaemic effects when 100% ...
Eligibility Criteria
Inclusion
- individuals (aged 25-75 years) with up to 8 years of T2DM, according to ADA criteria (Two-hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during OGTT. The test should be performed as described by the WHO, using a glucose load containing the equivalent of 75-g anhydrous glucose dissolved in water; or HbA1c \> ≥6.5% (48 mmol/mol)).
Exclusion
- pregnancy,
- participants on exogenous insulin therapy,
- HbA1c \>8.5%,
- BMI \<22 or \>35 kg/m²,
- regular smokers (\>1 cigarette per day),
- participants with established cardiovascular disease,
- neurological disease,
- cancer,
- renal disease.
- Participants who are unwilling to consume any of the standard foods/drinks
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2024
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04412798
Start Date
May 1 2020
End Date
April 1 2024
Last Update
May 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hasselt University
Hasselt, Belgium, 3500